Anastrozole CAS 120511-73-1 API Factory High Quality

Tlhaloso e Khutšoanyane:

Lebitso: Anastrozole

CAS: 120511-73-1

Ponahalo: Bosoeu ho isa ho Bosoeu ba Crystalline Powder

Tekanyo: 98.0% ~ 102.0%

AnastrozoleKalafo ea Kankere ea Matsoele

API Boleng bo Phahameng, Tlhahiso ea Khoebo

Inquiry: alvin@ruifuchem.com


Lintlha tsa Sehlahisoa

Lihlahisoa tse Amanang

Li-tag tsa Sehlahisoa

Tlhaloso:

Phepelo ea Moetsi e nang le Bohloeki bo Phahameng le Boleng bo tsitsitseng
Lebitso la lik'hemik'hale: Anastrozole
CAS: 120511-73-1

Lintho tsa Lik'hemik'hale:

Lebitso Anastrozole
Litlhaloso tse tšoanang Arimidex;α,α,α',α'-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetonitrile
Nomoro ea CAS 120511-73-1
Nomoro ea KAtse RF-API74
Boemo ba Setoko Ka Setokong, Phatlalatso e Eketsehile ho fihla ho Makholo a Lik'hilograma
Foromo ea limolek'hule C17H19N5
Boima ba Molek'hule 293.37
Solubility E qhibiliha ka DMSO le Ethanol
Brand Ruifu Chemical

 

Litlhaloso:

Ntho Litlhaloso
Ponahalo Phofo ea Crystalline e tšoeu ho isa ho e tšoeu
Boitsebiso A IR/MS E Ikamahanya le maemo a litšupiso
Boitsebiso B HPLC le sebopeho sa tlhoro: E tsamaellana le litšupiso
Melting Point 81.0 ~ 84.0℃
Litaba tsa Metsi (ka KF) ≤0.30%
Masalla a ho Ignition ≤0.10%
Tahlehelo ka ho Omisa ≤0.50%
Litšepe tse boima ≤10ppm
Lintho Tse Amanang
Tšilafalo A ≤0.10%
Tšilafalo B ≤0.20%
Tšilafalo C ≤0.20%
Tšilafalo D ≤0.10%
Tšilafalo E ≤0.10%
Tšilafalo e 'Ngoe ≤0.10%
Litšila ka Kakaretso ≤0.50%
Metsoako e setseng
Cyclohexane ≤0.30%
Ethyl Acetate ≤0.50%
Tlhahlobo 98.0% ~ 102.0% (ka motheo o omisitsoeng)
Shelf Life Likhoeli tse 24
Tekanyetso ea Teko Maemo a Khoebo;United States Pharmacopoeia (USP) Standard
Tšebeliso Kalafo ea Kankere ea Matsoele

Sephutheloana le Bobolokelo:

Sephutheloana: Botlolo, Aluminium foil bag, Cardboard drum, 25kg/Drum, kapa ho latela tlhoko ea moreki.

Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa khanya, mongobo le ho hlaseloa ke likokoanyana.

Melemo:

1

LBH:

Kopo:

Anastrozole (CAS 120511-73-1), ke motsoako o seng oa steroidal, oa moloko oa boraro oa achiral triazole o rekisoang e le ARIMIDEX® ke AstraZeneca Pharmaceuticals LP1.Ke e 'ngoe ea moloko oa boraro oa aromatase inhibitor e leng inhibitor e nang le tlhōlisano le e khethollang ea aromatase, kahoo e thibela phetoho ea testosterone ho estradiol le androstenedione ho estrone.Thibelo ea enzyme ea aromatase e etsahala haholo-holo ka tlholisano ea tlamahano ea aromatase ho hemegroup ea cytochrome P450, ho fokotsa biosynthesis ea estrogen liseleng tsa peripheral tsa 'mele le letsoeleng.

Anastrozole ke kalafo e mamelloang hantle bakeng sa mofetše oa matsoele o sa tsoa qala.Joalo ka li-inhibitors tse ling tsa aromatase, phello ea eona e mpe ka ho fetisisa e ne e le kotsi e eketsehileng ea ho robeha ha masapo, eo bakeng sa anastrozole e neng e lekanyelitsoe ho nako ea kalafo.E na le chefo e bobebe ha e bapisoa le chemotherapy;leha ho le joalo, ho hlokometsoe hore bakuli ba bangata ba phekoloang ka anastrozole ba 'nile ba tletleba ka matšoao a manonyeletso ho feta kamoo ho neng ho lebeletsoe kateng, haholo-holo ho tiea ha digital ho tšoana le lefu la ramatiki.Liteko tse ling tsa bongaka tsa anastrozole bakeng sa basali ba postmenopausal ba nang le mofetše oa matsoele Europe le United States li tlalehile mafu a mesifa le masapo e le liketsahalo tse mpe.Anastrozole (Arimidex®) ke aromatase inhibitor e amohetsoeng ho EU, US le linaheng tse ling lefatšeng ka bophara bakeng sa ho sebelisoa e le phekolo ea adjuvant ho basali ba postmenopausal ba nang le kankere ea matsoele ea pele, hormone receptor-positive.E boetse e amohetsoe ho EU le linaheng tse ling lefatšeng ka bophara bakeng sa ho tsoela pele kalafo ea adjuvant ho basali ba seng ba ntse ba e-na le lilemo tse 2-3 tsa phekolo ea adjuvant tamoxifen bakeng sa kankere ea matsoele.

Ngola molaetsa wa hao mona mme o re romele wona